Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

Nina S. Kjellson, a director at Tyra Biosciences , Inc. (NASDAQ:TYRA), recently sold shares of the company's common stock totaling $74,323. The timing of this insider sale comes as the stock trades ...

while being agnostic for the FGFR3 gatekeeper mutations. TYRA-300 is expected to be evaluated in three Phase 2 studies: SURF302 for IR NMIBC, BEACH301 for pediatric achondroplasia and SURF301 for ...

These results demonstrate that FOXG1 suppresses Fgfr3 gene expression and the MAPK/ERK pathway, and loss of Foxg1 results in an enhancement of this pro-gliogenic pathway. The decline in nuclear FOXG1 ...

The shares of Dixon Technologies (India) Ltd were trading at ₹15,551.85 down by 2007.60 or 11.43 percent on the NSE today at 10.20 am. Dixon Technologies (India) Ltd reported a consolidated net ...

3M reported Q4 adjusted sales of $5.808 billion, up 2.22% YoY, beating consensus expectations of $5.781 billion. Adjusted organic sales grew 2.1% despite a 70-basis-point headwind from portfolio ...

Their findings, published in Nature Aging, describe a never-before-seen link between the two most accepted explanations: random genetic mutations and predictable epigenetic modifications.

Taiwanese expect GDP growth this year to approach 3 percent and the TAIEX to rally above 24,000 points, as major local technology firms benefit further from artificial intelligence (AI) applications, ...

Inflation continues to erode purchasing power, and recent volatility highlights the uncertainty in inflation trends. Despite this, long-term investors can still find opportunities. In an ...

Axis Bank Q3 Results LIVE Updates: Mumbai-based private lender Axis Bank Ltd. reported results for the December quarter, which were in-line with expectations. Net Interest Income increased by 8.6% ...